FDA approves Xacduro injection (Durlobactam, a new molecular entity in combination with sulbactam) for treatment of hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia caused by bacteria called Acinetobacter baumannii-calcoaceticus complex Read More..
Leave a Comment
You must be logged in to post a comment.